RGDO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RGDO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Regado Biosciences's sale of property, plant, equipment for the three months ended in Jun. 2016 was $0.00 Mil. It means Regado Biosciences gained $0.00 Mil from selling property, plant, and equipment. Regado Biosciences's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Jun. 2016 was $0.00 Mil.
Compared with last quarter ($0.00 Mil in Mar. 2016 ), Regado Biosciences gained the same money from selling property, plant, and equipment in Jun. 2016 ($0.00 Mil).
The historical data trend for Regado Biosciences's Sale Of Property, Plant, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regado Biosciences Annual Data | |||||||||||
Trend | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | ||||||
Sale Of Property, Plant, Equipment | - | - | - | - | - |
Regado Biosciences Quarterly Data | |||||||||||||||||||
Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | |
Sale Of Property, Plant, Equipment | Get a 7-Day Free Trial | - | - | - | - | - |
The amount earned to sell PPE.
Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Regado Biosciences's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.
Domain Parters Vii L P | 10 percent owner | ONE PALMER SQUARE SUITE 515, PRINCETON NJ 08542 |
Associates Domain | 10 percent owner | ONE PALMER SQUARE, PRINCETON NJ 08542 |
Dp Vi Associates, L.p. | 10 percent owner | ONE PALMER SQUARE, PRINCETON NJ 08542 |
Brian K Halak | 10 percent owner | C/O DOMAIN ASSOCIATES, ONE PALMER SQUARE, PRINCETON NJ 08542 |
Kim P. Kamdar | 10 percent owner | C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542 |
Eckard Weber | director | C/O DOMAIN ASSOCIATES, ONE PALO SQ, PRINCETON NJ 08542 |
Brian H Dovey | 10 percent owner | ONE PALMER SQUARE, PRINCETON NJ 08542 |
Patrick J Heron | director | 550 HAMILTON AVE., SUITE 100, PALO ALTO CA 94301 |
Dp Vii Associates Lp | 10 percent owner | ONE PALMER SQ, STE 515, PRINCETON NJ 08542 |
Jeffrey H Cooper | director | BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE, NOVATO CA 94949 |
Pierre Legault | director | P.O. BOX 1028, C/O STONE MANAGEMENT LLC, BERWYNE PA 19312 |
Frazier Healthcare V, Lp | 10 percent owner | 601 UNION STREET, SUITE 3200, SEATTLE WA 98101 |
Christopher Peetz | officer: Chief Financial Officer | C/O TOBIRA THERAPEUTICS, INC., 701 GATEWAY BOULEVARD, #200, SOUTH SAN FRANCISCO CA 94080 |
Andrew J. Fromkin | director | C/O RADIUS HEALTH, INC., 201 BROADWAY, 6TH FL, CAMBRIDGE MA 02139 |
Carol L Brosgart | director | C/O TOBIRA THERAPEUTICS, INC., 701 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO CA 94080 |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.